Chabiotech Co.,Ltd. (KOSDAQ:085660)
South Korea · Delayed Price · Currency is KRW 9,670.00
-50.00 (-0.51%)
Aug 12, 2026, 3:30 PM KST
Chabiotech Market Cap
Chabiotech has a market cap or net worth of 899.12 billion as of August 12, 2026. Its market cap has increased by 8.73% in one year.
Market Cap
899.12B
Enterprise Value
1.92T
Revenue
1.29T
Ranking
n/a
PE Ratio
n/a
Stock Price
9,670.00
ChartMarket Cap Chart
Since February 23, 2009, Chabiotech's market cap has increased from 334.13B to 899.12B, an increase of 169.09%. That is a compound annual growth rate of 5.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 894.50B | -20.09% |
| Dec 30, 2025 | 1.12T | 74.51% |
| Dec 30, 2024 | 641.46B | -41.85% |
| Dec 28, 2023 | 1.10T | 50.82% |
| Dec 29, 2022 | 731.49B | -34.83% |
| Dec 30, 2021 | 1.12T | 6.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kolon TissueGene | 1.67T |
| Orum Therapeutics | 1.54T |
| Hyundai Bioscience | 796.15B |
| Pharmicell | 695.45B |
| AbClon | 678.37B |
| Onconic Therapeutics | 674.31B |
| GI Innovation | 601.29B |
| Medy-Tox | 508.37B |